Table 2.
Cell line | Organism | Carcinogen | Differentiation degree | Gene mutation | Ref |
---|---|---|---|---|---|
PC1 | mouse | BOP | Good | K-ras, P53 | 97, 98 |
WDPaCa | mouse | BOP | Good | P53 | 99 |
PDPaCa | mouse | BOP | Poor | k-ras | 99 |
HPC | mouse | BOP | Poor | 100 | |
HP1 | mouse | BOP | 101 | ||
HaP-T1 | mouse | BOP | Good-Moderate | 102 | |
H2T | mouse | BHP | K-ras, P53 | 103, 104 | |
HPD(1-3)NR | mouse | BHP | Moderate | K-ras, P53 | 102, 105 |
Pan02 | mouse | MCA | K-ras,smad4 | 106 | |
6606PDA | mouse | Good | 107-109 | ||
AR42J | rat | 110, 111 |
Note: BHP: N-nitrosobis(2-hydroxypropyl)amine; animal-origin pancreatic cancer cell lines are commonly used in inbred mice of the same origin for allogeneic transplantation. This model is used more frequently in tumor immunology studies and to evaluate single-agent or combination immunotherapy studies.